Management of lateral pelvic lymph nodes in rectal cancer

Gloria Chang, Wissam J. Halabi, Fadwa Ali

Research output: Contribution to journalReview articlepeer-review

Abstract

Lateral pelvic lymph node (LPLN) involvement occurs in 10%–25% of rectal cancer cases. Total mesorectal excision (TME) with routine LPLN dissection (LPLND) is predominantly applied in Japan whereas TME with neoadjuvant treatment are used in the West. LPLND is a morbid procedure and minimally invasive techniques may help reduce its morbidity. Selective lateral pelvic node dissection with TME following neoadjuvant treatment achieves acceptable disease-free and overall survival.

Original languageEnglish (US)
Pages (from-to)1264-1270
Number of pages7
JournalJournal of Surgical Oncology
Volume127
Issue number8
DOIs
StatePublished - Jun 15 2023
Externally publishedYes

Keywords

  • lateral pelvic lymph nodes
  • pelvic lymphadenopathy
  • rectal adenocarcinoma
  • rectal cancer

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint

Dive into the research topics of 'Management of lateral pelvic lymph nodes in rectal cancer'. Together they form a unique fingerprint.

Cite this